Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- Author
- DAVIES, Christina1 ; HONGCHAO PAN1 ; BRADBURY, Joan9 ; CLARKE, Michael10 ; COLLINS, Rory1 ; DAVIS, Susan R9 ; DELMESTRI, Antonella1 ; FORBES, John F11 ; HADDAD, Peiman12 ; HOU, Ming-Feng13 ; INBAR, Moshe14 ; KHALED, Hussein7 ; GODWIN, Jon2 ; KIELANOWSKA, Joanna15 ; KWAN, Wing-Hong16 ; MATHEW, Beela S17 ; MITTRA, Indraneel18 ; MÜLLER, Bettina19 ; NICOLUCCI, Antonio20 ; PERALTA, Octavio19 ; PERNAS, Fany21 ; PETRUZELKA, Lubos22 ; PIENKOWSKI, Tadeusz23 ; GRAY, Richard1 ; RADHIKA, Ramachandran24 ; RAJAN, Balakrishnan25 ; RUBACH, Maryna T15 ; TORT, Sera8 ; URRUTIA, Gerard8 ; VALENTINI, Miriam20 ; YAOCHEN WANG1 ; PETO, Richard1 ; ARRIAGADA, Rodrigo3 ; RAINA, Vinod4 ; ABRAHAM, Mirta5 ; MEDEIROS ALENCAR, Victor Hugo6 ; BADRAN, Atef7 ; BONFILL, Xavier8
[1] Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford, United Kingdom
[2] Glasgow Caledonian University, Glasgow, United Kingdom
[3] Institut Gustave-Roussy, Villejuif, France
[4] Institute Rotary Cancer Hospital, All-India Institute of Medical Sciences, New Delhi, India
[5] Instituto Cardiovascular Rosario (ICR), Rosario, Argentina
[6] Institutodo Cancer do Ceará (ICC), Fortaleza, Brazil
[7] National Cancer Institute, Cairo University, Cairo, Egypt
[8] Sant Pau Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain
[9] School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
[10] Queens University, Belfast, United Kingdom
[11] Australia and New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle, NSW, Australia
[12] Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
[13] Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
[14] Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
[15] The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
[16] Comprehensive Oncology Centre, Hong-Kong
[17] Regional Cancer Centre, Trivandrum, India
[18] Tata Memorial Hospital, Mumbai, India
[19] Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile
[20] Consorzio Mario Negri Sud, S Maria Imbaro, Italy
[21] Instituto de Investigaciones Clinicas de Rosario, Rosario, Argentina
[22] Medical Faculty 1, Charles University, Prague, Czech Republic
[23] European Health Centre Otwock (ECZO), Warsaw, Poland
[24] Cancer Institute (WIA), Chennai, India
[25] The National Oncology Centre, Royal Hospital, Oman
Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group - Source
Lancet (British edition). 2013, Vol 381, Num 9869, pp 805-816, 12 p ; ref : 24 ref
- CODEN
- LANCAO
- ISSN
- 0140-6736
- Scientific domain
- General medicine general surgery
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Atlas (os) Cancer du sein Diagnostic Essai clinique Etude comparative Glande mammaire Long terme Médecine Oestrogène Randomisation Récepteur hormonal Récepteur oestrogène Tamoxifène Traitement adjuvant Tumeur maligne Antihormone Antioestrogène Cancer Composé non stéroïde Hormone ovarienne Hormone stéroïde sexuelle Modulateur sélectif des récepteurs aux oestrogènes Pathologie de la glande mammaire Pathologie du sein
- Keyword (en)
- Antineoplastic agent Atlas (bone) Breast cancer Diagnosis Clinical trial Comparative study Mammary gland Long term Medicine Estrogen Randomization Hormonal receptor Estrogen receptor Tamoxifene Adjuvant treatment Malignant tumor Antihormone Antiestrogen Cancer Non steroid compound Ovarian hormone Sex steroid hormone Selective estrogen receptor modulator Mammary gland diseases Breast disease
- Keyword (es)
- Anticanceroso Atlas (hueso) Cáncer del pecho Diagnóstico Ensayo clínico Estudio comparativo Glándula mamaria Largo plazo Medicina Estrógeno Aleatorización Receptor hormonal Receptor estrógeno Tamoxifeno Tratamiento adyuvante Tumor maligno Antihormona Antiestrógeno Cáncer Compuesto no esteroide Hormona ovárica Hormona esteroide sexual Modulador selectivo del receptor de estrógeno Glándula mamaria patología Seno patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Generalities in medical sciences Gynecology. Andrology. Obstetrics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27042632
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S0140-6736(12)61963-1 
https://dx.doi.org/10.1016/S0140-6736(12)61963-1
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(12)61963-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"381\";s:8:\"\u0000*\u0000issue\";s:4:\"9869\";s:8:\"\u0000*\u0000spage\";s:3:\"805\";s:8:\"\u0000*\u0000epage\";s:3:\"816\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DAVIES\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:37:{i:0;s:12:\"HONGCHAO PAN\";i:1;s:14:\"BRADBURY, Joan\";i:2;s:15:\"CLARKE, Michael\";i:3;s:13:\"COLLINS, Rory\";i:4;s:14:\"DAVIS, Susan R\";i:5;s:20:\"DELMESTRI, Antonella\";i:6;s:14:\"FORBES, John F\";i:7;s:14:\"HADDAD, Peiman\";i:8;s:14:\"HOU, Ming-Feng\";i:9;s:12:\"INBAR, Moshe\";i:10;s:15:\"KHALED, Hussein\";i:11;s:11:\"GODWIN, Jon\";i:12;s:19:\"KIELANOWSKA, Joanna\";i:13;s:15:\"KWAN, Wing-Hong\";i:14;s:15:\"MATHEW, Beela S\";i:15;s:17:\"MITTRA, Indraneel\";i:16;s:16:\"M\u00dcLLER, Bettina\";i:17;s:18:\"NICOLUCCI, Antonio\";i:18;s:16:\"PERALTA, Octavio\";i:19;s:12:\"PERNAS, Fany\";i:20;s:17:\"PETRUZELKA, Lubos\";i:21;s:19:\"PIENKOWSKI, Tadeusz\";i:22;s:13:\"GRAY, Richard\";i:23;s:21:\"RADHIKA, Ramachandran\";i:24;s:19:\"RAJAN, Balakrishnan\";i:25;s:16:\"RUBACH, Maryna T\";i:26;s:10:\"TORT, Sera\";i:27;s:15:\"URRUTIA, Gerard\";i:28;s:17:\"VALENTINI, Miriam\";i:29;s:12:\"YAOCHEN WANG\";i:30;s:13:\"PETO, Richard\";i:31;s:18:\"ARRIAGADA, Rodrigo\";i:32;s:12:\"RAINA, Vinod\";i:33;s:14:\"ABRAHAM, Mirta\";i:34;s:29:\"MEDEIROS ALENCAR, Victor Hugo\";i:35;s:12:\"BADRAN, Atef\";i:36;s:15:\"BONFILL, Xavier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(12)61963-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"381\";s:8:\"\u0000*\u0000issue\";s:4:\"9869\";s:8:\"\u0000*\u0000spage\";s:3:\"805\";s:8:\"\u0000*\u0000epage\";s:3:\"816\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DAVIES\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:37:{i:0;s:12:\"HONGCHAO PAN\";i:1;s:14:\"BRADBURY, Joan\";i:2;s:15:\"CLARKE, Michael\";i:3;s:13:\"COLLINS, Rory\";i:4;s:14:\"DAVIS, Susan R\";i:5;s:20:\"DELMESTRI, Antonella\";i:6;s:14:\"FORBES, John F\";i:7;s:14:\"HADDAD, Peiman\";i:8;s:14:\"HOU, Ming-Feng\";i:9;s:12:\"INBAR, Moshe\";i:10;s:15:\"KHALED, Hussein\";i:11;s:11:\"GODWIN, Jon\";i:12;s:19:\"KIELANOWSKA, Joanna\";i:13;s:15:\"KWAN, Wing-Hong\";i:14;s:15:\"MATHEW, Beela S\";i:15;s:17:\"MITTRA, Indraneel\";i:16;s:16:\"M\u00dcLLER, Bettina\";i:17;s:18:\"NICOLUCCI, Antonio\";i:18;s:16:\"PERALTA, Octavio\";i:19;s:12:\"PERNAS, Fany\";i:20;s:17:\"PETRUZELKA, Lubos\";i:21;s:19:\"PIENKOWSKI, Tadeusz\";i:22;s:13:\"GRAY, Richard\";i:23;s:21:\"RADHIKA, Ramachandran\";i:24;s:19:\"RAJAN, Balakrishnan\";i:25;s:16:\"RUBACH, Maryna T\";i:26;s:10:\"TORT, Sera\";i:27;s:15:\"URRUTIA, Gerard\";i:28;s:17:\"VALENTINI, Miriam\";i:29;s:12:\"YAOCHEN WANG\";i:30;s:13:\"PETO, Richard\";i:31;s:18:\"ARRIAGADA, Rodrigo\";i:32;s:12:\"RAINA, Vinod\";i:33;s:14:\"ABRAHAM, Mirta\";i:34;s:29:\"MEDEIROS ALENCAR, Victor Hugo\";i:35;s:12:\"BADRAN, Atef\";i:36;s:15:\"BONFILL, Xavier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(12)61963-1\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(12)61963-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"381\";s:8:\"\u0000*\u0000issue\";s:4:\"9869\";s:8:\"\u0000*\u0000spage\";s:3:\"805\";s:8:\"\u0000*\u0000epage\";s:3:\"816\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DAVIES\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:37:{i:0;s:12:\"HONGCHAO PAN\";i:1;s:14:\"BRADBURY, Joan\";i:2;s:15:\"CLARKE, Michael\";i:3;s:13:\"COLLINS, Rory\";i:4;s:14:\"DAVIS, Susan R\";i:5;s:20:\"DELMESTRI, Antonella\";i:6;s:14:\"FORBES, John F\";i:7;s:14:\"HADDAD, Peiman\";i:8;s:14:\"HOU, Ming-Feng\";i:9;s:12:\"INBAR, Moshe\";i:10;s:15:\"KHALED, Hussein\";i:11;s:11:\"GODWIN, Jon\";i:12;s:19:\"KIELANOWSKA, Joanna\";i:13;s:15:\"KWAN, Wing-Hong\";i:14;s:15:\"MATHEW, Beela S\";i:15;s:17:\"MITTRA, Indraneel\";i:16;s:16:\"M\u00dcLLER, Bettina\";i:17;s:18:\"NICOLUCCI, Antonio\";i:18;s:16:\"PERALTA, Octavio\";i:19;s:12:\"PERNAS, Fany\";i:20;s:17:\"PETRUZELKA, Lubos\";i:21;s:19:\"PIENKOWSKI, Tadeusz\";i:22;s:13:\"GRAY, Richard\";i:23;s:21:\"RADHIKA, Ramachandran\";i:24;s:19:\"RAJAN, Balakrishnan\";i:25;s:16:\"RUBACH, Maryna T\";i:26;s:10:\"TORT, Sera\";i:27;s:15:\"URRUTIA, Gerard\";i:28;s:17:\"VALENTINI, Miriam\";i:29;s:12:\"YAOCHEN WANG\";i:30;s:13:\"PETO, Richard\";i:31;s:18:\"ARRIAGADA, Rodrigo\";i:32;s:12:\"RAINA, Vinod\";i:33;s:14:\"ABRAHAM, Mirta\";i:34;s:29:\"MEDEIROS ALENCAR, Victor Hugo\";i:35;s:12:\"BADRAN, Atef\";i:36;s:15:\"BONFILL, Xavier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(12)61963-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"381\";s:8:\"\u0000*\u0000issue\";s:4:\"9869\";s:8:\"\u0000*\u0000spage\";s:3:\"805\";s:8:\"\u0000*\u0000epage\";s:3:\"816\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DAVIES\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:37:{i:0;s:12:\"HONGCHAO PAN\";i:1;s:14:\"BRADBURY, Joan\";i:2;s:15:\"CLARKE, Michael\";i:3;s:13:\"COLLINS, Rory\";i:4;s:14:\"DAVIS, Susan R\";i:5;s:20:\"DELMESTRI, Antonella\";i:6;s:14:\"FORBES, John F\";i:7;s:14:\"HADDAD, Peiman\";i:8;s:14:\"HOU, Ming-Feng\";i:9;s:12:\"INBAR, Moshe\";i:10;s:15:\"KHALED, Hussein\";i:11;s:11:\"GODWIN, Jon\";i:12;s:19:\"KIELANOWSKA, Joanna\";i:13;s:15:\"KWAN, Wing-Hong\";i:14;s:15:\"MATHEW, Beela S\";i:15;s:17:\"MITTRA, Indraneel\";i:16;s:16:\"M\u00dcLLER, Bettina\";i:17;s:18:\"NICOLUCCI, Antonio\";i:18;s:16:\"PERALTA, Octavio\";i:19;s:12:\"PERNAS, Fany\";i:20;s:17:\"PETRUZELKA, Lubos\";i:21;s:19:\"PIENKOWSKI, Tadeusz\";i:22;s:13:\"GRAY, Richard\";i:23;s:21:\"RADHIKA, Ramachandran\";i:24;s:19:\"RAJAN, Balakrishnan\";i:25;s:16:\"RUBACH, Maryna T\";i:26;s:10:\"TORT, Sera\";i:27;s:15:\"URRUTIA, Gerard\";i:28;s:17:\"VALENTINI, Miriam\";i:29;s:12:\"YAOCHEN WANG\";i:30;s:13:\"PETO, Richard\";i:31;s:18:\"ARRIAGADA, Rodrigo\";i:32;s:12:\"RAINA, Vinod\";i:33;s:14:\"ABRAHAM, Mirta\";i:34;s:29:\"MEDEIROS ALENCAR, Victor Hugo\";i:35;s:12:\"BADRAN, Atef\";i:36;s:15:\"BONFILL, Xavier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(12)61963-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"381\";s:8:\"\u0000*\u0000issue\";s:4:\"9869\";s:8:\"\u0000*\u0000spage\";s:3:\"805\";s:8:\"\u0000*\u0000epage\";s:3:\"816\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DAVIES\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Christina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:37:{i:0;s:12:\"HONGCHAO PAN\";i:1;s:14:\"BRADBURY, Joan\";i:2;s:15:\"CLARKE, Michael\";i:3;s:13:\"COLLINS, Rory\";i:4;s:14:\"DAVIS, Susan R\";i:5;s:20:\"DELMESTRI, Antonella\";i:6;s:14:\"FORBES, John F\";i:7;s:14:\"HADDAD, Peiman\";i:8;s:14:\"HOU, Ming-Feng\";i:9;s:12:\"INBAR, Moshe\";i:10;s:15:\"KHALED, Hussein\";i:11;s:11:\"GODWIN, Jon\";i:12;s:19:\"KIELANOWSKA, Joanna\";i:13;s:15:\"KWAN, Wing-Hong\";i:14;s:15:\"MATHEW, Beela S\";i:15;s:17:\"MITTRA, Indraneel\";i:16;s:16:\"M\u00dcLLER, Bettina\";i:17;s:18:\"NICOLUCCI, Antonio\";i:18;s:16:\"PERALTA, Octavio\";i:19;s:12:\"PERNAS, Fany\";i:20;s:17:\"PETRUZELKA, Lubos\";i:21;s:19:\"PIENKOWSKI, Tadeusz\";i:22;s:13:\"GRAY, Richard\";i:23;s:21:\"RADHIKA, Ramachandran\";i:24;s:19:\"RAJAN, Balakrishnan\";i:25;s:16:\"RUBACH, Maryna T\";i:26;s:10:\"TORT, Sera\";i:27;s:15:\"URRUTIA, Gerard\";i:28;s:17:\"VALENTINI, Miriam\";i:29;s:12:\"YAOCHEN WANG\";i:30;s:13:\"PETO, Richard\";i:31;s:18:\"ARRIAGADA, Rodrigo\";i:32;s:12:\"RAINA, Vinod\";i:33;s:14:\"ABRAHAM, Mirta\";i:34;s:29:\"MEDEIROS ALENCAR, Victor Hugo\";i:35;s:12:\"BADRAN, Atef\";i:36;s:15:\"BONFILL, Xavier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:177:\"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
